Clinical trials
Bronchitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Environmental Health Sciences (NIEHS) | 2 |
| Sumitomo Pharma America, Inc. | 2 |
| Abgenix | 1 |
| Adams Respiratory Therapeutics | 1 |
| AstraZeneca | 1 |
| Brigham and Women's Hospital | 1 |
| COPD Foundation | 1 |
| CPL Associates | 1 |
| Epic Research & Diagnostics, Inc. | 1 |
| Expedition Therapeutics, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchitis | 30 |
| Pulmonary Disease, Chronic Obstructive | 11 |
| Pneumonia | 9 |
| Bronchitis, Chronic | 7 |
| Emphysema | 7 |
| Respiratory Tract Infections | 7 |
| Asthma | 4 |
| Cough | 3 |
| Bronchiolitis | 2 |
| Diabetes Mellitus | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.